                               SEQUENCE LISTING

<110> JANUX THERAPEUTICS, INC.
 
<120> MODIFIED ANTIBODIES

<130> 52426-701.601

<140>
<141>

<150> 62/511,771
<151> 2017-05-26

<160> 70    

<170> PatentIn version 3.5

<210> 1
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(40)
<223> This sequence may encompass 6-20 'GS' repeating units
      wherein some positions may be absent

<400> 1
Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser 
1               5                   10                  15      


Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser 
            20                  25                  30          


Gly Ser Gly Ser Gly Ser Gly Ser 
        35                  40  


<210> 2
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(39)
<223> This sequence may encompass 4-13 'GGS' repeating 
      units wherein some positions may be absent

<400> 2
Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly 
1               5                   10                  15      


Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly 
            20                  25                  30          


Ser Gly Gly Ser Gly Gly Ser 
        35                  


<210> 3
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(40)
<223> This sequence may encompass 3-10 'GGGS' repeating 
      units wherein some positions may be absent

<400> 3
Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser 
1               5                   10                  15      


Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser 
            20                  25                  30          


Gly Gly Gly Ser Gly Gly Gly Ser 
        35                  40  


<210> 4
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(40)
<223> This sequence may encompass 2-8 'GGGGS' 
      repeating units wherein some positions may be absent

<400> 4
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly 
1               5                   10                  15      


Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly 
            20                  25                  30          


Gly Gly Ser Gly Gly Gly Gly Ser 
        35                  40  


<210> 5
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(40)
<223> This sequence may encompass 12-40 'G' repeating 
      units wherein some positions may be absent

<400> 5
Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
1               5                   10                  15      


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
            20                  25                  30          


Gly Gly Gly Gly Gly Gly Gly Gly 
        35                  40  


<210> 6
<211> 33
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(33)
<223> This sequence may encompass 1-3 'GGGSGSGGGGS' repeating 
      units wherein some positions may be absent

<400> 6
Gly Gly Gly Ser Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Ser Gly 
1               5                   10                  15      


Ser Gly Gly Gly Gly Ser Gly Gly Gly Ser Gly Ser Gly Gly Gly Gly 
            20                  25                  30          


Ser 
    


<210> 7
<211> 33
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(33)
<223> This sequence may encompass 1-3 'GGGGGPGGGGP' repeating 
      units wherein some positions may be absent

<400> 7
Gly Gly Gly Gly Gly Pro Gly Gly Gly Gly Pro Gly Gly Gly Gly Gly 
1               5                   10                  15      


Pro Gly Gly Gly Gly Pro Gly Gly Gly Gly Gly Pro Gly Gly Gly Gly 
            20                  25                  30          


Pro 
    


<210> 8
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(36)
<223> This sequence may encompass 2-6 'GGSGGD' repeating 
      units wherein some positions may be absent

<400> 8
Gly Gly Ser Gly Gly Asp Gly Gly Ser Gly Gly Asp Gly Gly Ser Gly 
1               5                   10                  15      


Gly Asp Gly Gly Ser Gly Gly Asp Gly Gly Ser Gly Gly Asp Gly Gly 
            20                  25                  30          


Ser Gly Gly Asp 
        35      


<210> 9
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(36)
<223> This sequence may encompass 2-6 'GGSGGE' repeating 
      units wherein some positions may be absent

<400> 9
Gly Gly Ser Gly Gly Glu Gly Gly Ser Gly Gly Glu Gly Gly Ser Gly 
1               5                   10                  15      


Gly Glu Gly Gly Ser Gly Gly Glu Gly Gly Ser Gly Gly Glu Gly Gly 
            20                  25                  30          


Ser Gly Gly Glu 
        35      


<210> 10
<211> 116
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(40)
<223> This region may encompass 0-20 'GS' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (41)..(76)
<223> This region may encompass 2-6 'GGSGGD' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (77)..(116)
<223> This region may encompass 0-20 'GS' repeating 
      units wherein some positions may be absent

<400> 10
Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser 
1               5                   10                  15      


Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser 
            20                  25                  30          


Gly Ser Gly Ser Gly Ser Gly Ser Gly Gly Ser Gly Gly Asp Gly Gly 
        35                  40                  45              


Ser Gly Gly Asp Gly Gly Ser Gly Gly Asp Gly Gly Ser Gly Gly Asp 
    50                  55                  60                  


Gly Gly Ser Gly Gly Asp Gly Gly Ser Gly Gly Asp Gly Ser Gly Ser 
65                  70                  75                  80  


Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser 
                85                  90                  95      


Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser 
            100                 105                 110         


Gly Ser Gly Ser 
        115     


<210> 11
<211> 114
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(39)
<223> This region may encompass 0-13 'GGS' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (40)..(75)
<223> This region may encompass 2-6 'GGSGGD' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (76)..(114)
<223> This region may encompass 0-13 'GGS' repeating 
      units wherein some positions may be absent

<400> 11
Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly 
1               5                   10                  15      


Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly 
            20                  25                  30          


Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Asp Gly Gly Ser 
        35                  40                  45              


Gly Gly Asp Gly Gly Ser Gly Gly Asp Gly Gly Ser Gly Gly Asp Gly 
    50                  55                  60                  


Gly Ser Gly Gly Asp Gly Gly Ser Gly Gly Asp Gly Gly Ser Gly Gly 
65                  70                  75                  80  


Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser 
                85                  90                  95      


Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly 
            100                 105                 110         


Gly Ser 
        


<210> 12
<211> 116
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(40)
<223> This region may encompass 0-10 'GGGS' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (41)..(76)
<223> This region may encompass 2-6 'GGSGGD' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (77)..(116)
<223> This region may encompass 0-10 'GGGS' repeating 
      units wherein some positions may be absent

<400> 12
Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser 
1               5                   10                  15      


Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser 
            20                  25                  30          


Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Ser Gly Gly Asp Gly Gly 
        35                  40                  45              


Ser Gly Gly Asp Gly Gly Ser Gly Gly Asp Gly Gly Ser Gly Gly Asp 
    50                  55                  60                  


Gly Gly Ser Gly Gly Asp Gly Gly Ser Gly Gly Asp Gly Gly Gly Ser 
65                  70                  75                  80  


Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser 
                85                  90                  95      


Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser 
            100                 105                 110         


Gly Gly Gly Ser 
        115     


<210> 13
<211> 116
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(40)
<223> This region may encompass 0-8 'GGGGS' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (41)..(76)
<223> This region may encompass 2-6 'GGSGGD' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (77)..(116)
<223> This region may encompass 0-8 'GGGGS' repeating 
      units wherein some positions may be absent

<400> 13
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly 
1               5                   10                  15      


Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly 
            20                  25                  30          


Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Ser Gly Gly Asp Gly Gly 
        35                  40                  45              


Ser Gly Gly Asp Gly Gly Ser Gly Gly Asp Gly Gly Ser Gly Gly Asp 
    50                  55                  60                  


Gly Gly Ser Gly Gly Asp Gly Gly Ser Gly Gly Asp Gly Gly Gly Gly 
65                  70                  75                  80  


Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
                85                  90                  95      


Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly 
            100                 105                 110         


Gly Gly Gly Ser 
        115     


<210> 14
<211> 116
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(40)
<223> This region may encompass 0-40 'G' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (41)..(76)
<223> This region may encompass 2-6 'GGSGGD' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (77)..(116)
<223> This region may encompass 0-40 'G' repeating 
      units wherein some positions may be absent

<400> 14
Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
1               5                   10                  15      


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
            20                  25                  30          


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Ser Gly Gly Asp Gly Gly 
        35                  40                  45              


Ser Gly Gly Asp Gly Gly Ser Gly Gly Asp Gly Gly Ser Gly Gly Asp 
    50                  55                  60                  


Gly Gly Ser Gly Gly Asp Gly Gly Ser Gly Gly Asp Gly Gly Gly Gly 
65                  70                  75                  80  


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
                85                  90                  95      


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
            100                 105                 110         


Gly Gly Gly Gly 
        115     


<210> 15
<211> 102
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(33)
<223> This region may encompass 0-3 'GGGSGSGGGGS' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (34)..(69)
<223> This region may encompass 2-6 'GGSGGD' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (70)..(102)
<223> This region may encompass 0-3 'GGGSGSGGGGS' repeating 
      units wherein some positions may be absent

<400> 15
Gly Gly Gly Ser Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Ser Gly 
1               5                   10                  15      


Ser Gly Gly Gly Gly Ser Gly Gly Gly Ser Gly Ser Gly Gly Gly Gly 
            20                  25                  30          


Ser Gly Gly Ser Gly Gly Asp Gly Gly Ser Gly Gly Asp Gly Gly Ser 
        35                  40                  45              


Gly Gly Asp Gly Gly Ser Gly Gly Asp Gly Gly Ser Gly Gly Asp Gly 
    50                  55                  60                  


Gly Ser Gly Gly Asp Gly Gly Gly Ser Gly Ser Gly Gly Gly Gly Ser 
65                  70                  75                  80  


Gly Gly Gly Ser Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Ser Gly 
                85                  90                  95      


Ser Gly Gly Gly Gly Ser 
            100         


<210> 16
<211> 102
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(33)
<223> This region may encompass 0-3 'GGGSGSGGGGP' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (34)..(69)
<223> This region may encompass 2-6 'GGSGGD' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (70)..(102)
<223> This region may encompass 0-3 'GGGSGSGGGGP' repeating 
      units wherein some positions may be absent

<400> 16
Gly Gly Gly Ser Gly Ser Gly Gly Gly Gly Pro Gly Gly Gly Ser Gly 
1               5                   10                  15      


Ser Gly Gly Gly Gly Pro Gly Gly Gly Ser Gly Ser Gly Gly Gly Gly 
            20                  25                  30          


Pro Gly Gly Ser Gly Gly Asp Gly Gly Ser Gly Gly Asp Gly Gly Ser 
        35                  40                  45              


Gly Gly Asp Gly Gly Ser Gly Gly Asp Gly Gly Ser Gly Gly Asp Gly 
    50                  55                  60                  


Gly Ser Gly Gly Asp Gly Gly Gly Ser Gly Ser Gly Gly Gly Gly Pro 
65                  70                  75                  80  


Gly Gly Gly Ser Gly Ser Gly Gly Gly Gly Pro Gly Gly Gly Ser Gly 
                85                  90                  95      


Ser Gly Gly Gly Gly Pro 
            100         


<210> 17
<211> 116
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(40)
<223> This region may encompass 0-20 'GS' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (41)..(76)
<223> This region may encompass 2-6 'GGSGGE' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (77)..(116)
<223> This region may encompass 0-20 'GS' repeating 
      units wherein some positions may be absent

<400> 17
Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser 
1               5                   10                  15      


Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser 
            20                  25                  30          


Gly Ser Gly Ser Gly Ser Gly Ser Gly Gly Ser Gly Gly Glu Gly Gly 
        35                  40                  45              


Ser Gly Gly Glu Gly Gly Ser Gly Gly Glu Gly Gly Ser Gly Gly Glu 
    50                  55                  60                  


Gly Gly Ser Gly Gly Glu Gly Gly Ser Gly Gly Glu Gly Ser Gly Ser 
65                  70                  75                  80  


Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser 
                85                  90                  95      


Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser Gly Ser 
            100                 105                 110         


Gly Ser Gly Ser 
        115     


<210> 18
<211> 114
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(39)
<223> This region may encompass 0-13 'GGS' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (40)..(75)
<223> This region may encompass 2-6 'GGSGGE' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (76)..(114)
<223> This region may encompass 0-13 'GGS' repeating 
      units wherein some positions may be absent

<400> 18
Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly 
1               5                   10                  15      


Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly 
            20                  25                  30          


Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Glu Gly Gly Ser 
        35                  40                  45              


Gly Gly Glu Gly Gly Ser Gly Gly Glu Gly Gly Ser Gly Gly Glu Gly 
    50                  55                  60                  


Gly Ser Gly Gly Glu Gly Gly Ser Gly Gly Glu Gly Gly Ser Gly Gly 
65                  70                  75                  80  


Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser 
                85                  90                  95      


Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly 
            100                 105                 110         


Gly Ser 
        


<210> 19
<211> 116
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(40)
<223> This region may encompass 0-10 'GGGS' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (41)..(76)
<223> This region may encompass 2-6 'GGSGGE' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (77)..(116)
<223> This region may encompass 0-10 'GGGS' repeating 
      units wherein some positions may be absent

<400> 19
Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser 
1               5                   10                  15      


Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser 
            20                  25                  30          


Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Ser Gly Gly Glu Gly Gly 
        35                  40                  45              


Ser Gly Gly Glu Gly Gly Ser Gly Gly Glu Gly Gly Ser Gly Gly Glu 
    50                  55                  60                  


Gly Gly Ser Gly Gly Glu Gly Gly Ser Gly Gly Glu Gly Gly Gly Ser 
65                  70                  75                  80  


Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser 
                85                  90                  95      


Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser Gly Gly Gly Ser 
            100                 105                 110         


Gly Gly Gly Ser 
        115     


<210> 20
<211> 116
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(40)
<223> This region may encompass 0-8 'GGGGS' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (41)..(76)
<223> This region may encompass 2-6 'GGSGGE' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (77)..(116)
<223> This region may encompass 0-8 'GGGGS' repeating 
      units wherein some positions may be absent

<400> 20
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly 
1               5                   10                  15      


Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly 
            20                  25                  30          


Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Ser Gly Gly Glu Gly Gly 
        35                  40                  45              


Ser Gly Gly Glu Gly Gly Ser Gly Gly Glu Gly Gly Ser Gly Gly Glu 
    50                  55                  60                  


Gly Gly Ser Gly Gly Glu Gly Gly Ser Gly Gly Glu Gly Gly Gly Gly 
65                  70                  75                  80  


Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
                85                  90                  95      


Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly 
            100                 105                 110         


Gly Gly Gly Ser 
        115     


<210> 21
<211> 116
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(40)
<223> This region may encompass 0-40 'G' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (41)..(76)
<223> This region may encompass 2-6 'GGSGGE' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (77)..(116)
<223> This region may encompass 0-40 'G' repeating 
      units wherein some positions may be absent

<400> 21
Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
1               5                   10                  15      


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
            20                  25                  30          


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Ser Gly Gly Glu Gly Gly 
        35                  40                  45              


Ser Gly Gly Glu Gly Gly Ser Gly Gly Glu Gly Gly Ser Gly Gly Glu 
    50                  55                  60                  


Gly Gly Ser Gly Gly Glu Gly Gly Ser Gly Gly Glu Gly Gly Gly Gly 
65                  70                  75                  80  


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
                85                  90                  95      


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
            100                 105                 110         


Gly Gly Gly Gly 
        115     


<210> 22
<211> 102
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(33)
<223> This region may encompass 0-3 'GGGSGSGGGGS' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (34)..(69)
<223> This region may encompass 2-6 'GGSGGE' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (70)..(102)
<223> This region may encompass 0-3 'GGGSGSGGGGS' repeating 
      units wherein some positions may be absent

<400> 22
Gly Gly Gly Ser Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Ser Gly 
1               5                   10                  15      


Ser Gly Gly Gly Gly Ser Gly Gly Gly Ser Gly Ser Gly Gly Gly Gly 
            20                  25                  30          


Ser Gly Gly Ser Gly Gly Glu Gly Gly Ser Gly Gly Glu Gly Gly Ser 
        35                  40                  45              


Gly Gly Glu Gly Gly Ser Gly Gly Glu Gly Gly Ser Gly Gly Glu Gly 
    50                  55                  60                  


Gly Ser Gly Gly Glu Gly Gly Gly Ser Gly Ser Gly Gly Gly Gly Ser 
65                  70                  75                  80  


Gly Gly Gly Ser Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Ser Gly 
                85                  90                  95      


Ser Gly Gly Gly Gly Ser 
            100         


<210> 23
<211> 102
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<220> 
<221> MISC_FEATURE
<222> (1)..(33)
<223> This region may encompass 0-3 'GGGSGSGGGGP' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (34)..(69)
<223> This region may encompass 2-6 'GGSGGE' repeating 
      units wherein some positions may be absent

<220> 
<221> MISC_FEATURE
<222> (70)..(102)
<223> This region may encompass 0-3 'GGGSGSGGGGP' repeating 
      units wherein some positions may be absent

<400> 23
Gly Gly Gly Ser Gly Ser Gly Gly Gly Gly Pro Gly Gly Gly Ser Gly 
1               5                   10                  15      


Ser Gly Gly Gly Gly Pro Gly Gly Gly Ser Gly Ser Gly Gly Gly Gly 
            20                  25                  30          


Pro Gly Gly Ser Gly Gly Glu Gly Gly Ser Gly Gly Glu Gly Gly Ser 
        35                  40                  45              


Gly Gly Glu Gly Gly Ser Gly Gly Glu Gly Gly Ser Gly Gly Glu Gly 
    50                  55                  60                  


Gly Ser Gly Gly Glu Gly Gly Gly Ser Gly Ser Gly Gly Gly Gly Pro 
65                  70                  75                  80  


Gly Gly Gly Ser Gly Ser Gly Gly Gly Gly Pro Gly Gly Gly Ser Gly 
                85                  90                  95      


Ser Gly Gly Gly Gly Pro 
            100         


<210> 24
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(40)
<223> This sequence may encompass at least 20 'GX' repeating 
      units wherein some positions may be absent

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (24)..(24)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (26)..(26)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (28)..(28)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (30)..(30)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (32)..(32)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (34)..(34)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (36)..(36)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (38)..(38)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (40)..(40)
<223> Ser, Asp, Glu, Thr or Pro

<400> 24
Gly Xaa Gly Xaa Gly Xaa Gly Xaa Gly Xaa Gly Xaa Gly Xaa Gly Xaa 
1               5                   10                  15      


Gly Xaa Gly Xaa Gly Xaa Gly Xaa Gly Xaa Gly Xaa Gly Xaa Gly Xaa 
            20                  25                  30          


Gly Xaa Gly Xaa Gly Xaa Gly Xaa 
        35                  40  


<210> 25
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(39)
<223> This sequence may encompass at least 13 'GGX' repeating 
      units wherein some positions may be absent

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (24)..(24)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (27)..(27)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (30)..(30)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (33)..(33)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (36)..(36)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (39)..(39)
<223> Ser, Asp, Glu, Thr or Pro

<400> 25
Gly Gly Xaa Gly Gly Xaa Gly Gly Xaa Gly Gly Xaa Gly Gly Xaa Gly 
1               5                   10                  15      


Gly Xaa Gly Gly Xaa Gly Gly Xaa Gly Gly Xaa Gly Gly Xaa Gly Gly 
            20                  25                  30          


Xaa Gly Gly Xaa Gly Gly Xaa 
        35                  


<210> 26
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(40)
<223> This sequence may encompass at least 10 'GGGX' repeating 
      units wherein some positions may be absent

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (24)..(24)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (28)..(28)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (32)..(32)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (36)..(36)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (40)..(40)
<223> Ser, Asp, Glu, Thr or Pro

<400> 26
Gly Gly Gly Xaa Gly Gly Gly Xaa Gly Gly Gly Xaa Gly Gly Gly Xaa 
1               5                   10                  15      


Gly Gly Gly Xaa Gly Gly Gly Xaa Gly Gly Gly Xaa Gly Gly Gly Xaa 
            20                  25                  30          


Gly Gly Gly Xaa Gly Gly Gly Xaa 
        35                  40  


<210> 27
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(40)
<223> This sequence may encompass at least 8 'GGGGX' repeating 
      units wherein some positions may be absent

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (25)..(25)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (30)..(30)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (35)..(35)
<223> Ser, Asp, Glu, Thr or Pro

<220>
<221> MOD_RES
<222> (40)..(40)
<223> Ser, Asp, Glu, Thr or Pro

<400> 27
Gly Gly Gly Gly Xaa Gly Gly Gly Gly Xaa Gly Gly Gly Gly Xaa Gly 
1               5                   10                  15      


Gly Gly Gly Xaa Gly Gly Gly Gly Xaa Gly Gly Gly Gly Xaa Gly Gly 
            20                  25                  30          


Gly Gly Xaa Gly Gly Gly Gly Xaa 
        35                  40  


<210> 28
<211> 315
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220> 
<221> MISC_FEATURE
<222> (1)..(315)
<223> This sequence may encompass at least 15 'GZX' 
      repeating units wherein 'Z' is an integer between
      1-20 and some positions may be absent 

<220> 
<221> MISC_FEATURE
<222> (1)..(20)
<223> This region may encompass 1-20 'G' repeating 
      units wherein some positions may be absent

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Ser, Asp, Glu, Thr or Pro

<220> 
<221> MISC_FEATURE
<222> (22)..(41)
<223> This region may encompass 1-20 'G' repeating 
      units wherein some positions may be absent

<220>
<221> MOD_RES
<222> (42)..(42)
<223> Ser, Asp, Glu, Thr or Pro

<220> 
<221> MISC_FEATURE
<222> (43)..(62)
<223> This region may encompass 1-20 'G' repeating 
      units wherein some positions may be absent

<220>
<221> MOD_RES
<222> (63)..(63)
<223> Ser, Asp, Glu, Thr or Pro

<220> 
<221> MISC_FEATURE
<222> (64)..(83)
<223> This region may encompass 1-20 'G' repeating 
      units wherein some positions may be absent

<220>
<221> MOD_RES
<222> (84)..(84)
<223> Ser, Asp, Glu, Thr or Pro

<220> 
<221> MISC_FEATURE
<222> (85)..(104)
<223> This region may encompass 1-20 'G' repeating 
      units wherein some positions may be absent

<220>
<221> MOD_RES
<222> (105)..(105)
<223> Ser, Asp, Glu, Thr or Pro

<220> 
<221> MISC_FEATURE
<222> (106)..(125)
<223> This region may encompass 1-20 'G' repeating 
      units wherein some positions may be absent

<220>
<221> MOD_RES
<222> (126)..(126)
<223> Ser, Asp, Glu, Thr or Pro

<220> 
<221> MISC_FEATURE
<222> (127)..(146)
<223> This region may encompass 1-20 'G' repeating 
      units wherein some positions may be absent

<220>
<221> MOD_RES
<222> (147)..(147)
<223> Ser, Asp, Glu, Thr or Pro

<220> 
<221> MISC_FEATURE
<222> (148)..(167)
<223> This region may encompass 1-20 'G' repeating 
      units wherein some positions may be absent

<220>
<221> MOD_RES
<222> (168)..(168)
<223> Ser, Asp, Glu, Thr or Pro

<220> 
<221> MISC_FEATURE
<222> (169)..(188)
<223> This region may encompass 1-20 'G' repeating 
      units wherein some positions may be absent

<220>
<221> MOD_RES
<222> (189)..(189)
<223> Ser, Asp, Glu, Thr or Pro

<220> 
<221> MISC_FEATURE
<222> (190)..(209)
<223> This region may encompass 1-20 'G' repeating 
      units wherein some positions may be absent

<220>
<221> MOD_RES
<222> (210)..(210)
<223> Ser, Asp, Glu, Thr or Pro

<220> 
<221> MISC_FEATURE
<222> (211)..(230)
<223> This region may encompass 1-20 'G' repeating 
      units wherein some positions may be absent

<220>
<221> MOD_RES
<222> (231)..(231)
<223> Ser, Asp, Glu, Thr or Pro

<220> 
<221> MISC_FEATURE
<222> (232)..(251)
<223> This region may encompass 1-20 'G' repeating 
      units wherein some positions may be absent

<220>
<221> MOD_RES
<222> (252)..(252)
<223> Ser, Asp, Glu, Thr or Pro

<220> 
<221> MISC_FEATURE
<222> (253)..(272)
<223> This region may encompass 1-20 'G' repeating 
      units wherein some positions may be absent

<220>
<221> MOD_RES
<222> (273)..(273)
<223> Ser, Asp, Glu, Thr or Pro

<220> 
<221> MISC_FEATURE
<222> (274)..(293)
<223> This region may encompass 1-20 'G' repeating 
      units wherein some positions may be absent

<220>
<221> MOD_RES
<222> (294)..(294)
<223> Ser, Asp, Glu, Thr or Pro

<220> 
<221> MISC_FEATURE
<222> (295)..(314)
<223> This region may encompass 1-20 'G' repeating 
      units wherein some positions may be absent

<220>
<221> MOD_RES
<222> (315)..(315)
<223> Ser, Asp, Glu, Thr or Pro

<400> 28
Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
1               5                   10                  15      


Gly Gly Gly Gly Xaa Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
            20                  25                  30          


Gly Gly Gly Gly Gly Gly Gly Gly Gly Xaa Gly Gly Gly Gly Gly Gly 
        35                  40                  45              


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Xaa Gly 
    50                  55                  60                  


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
65                  70                  75                  80  


Gly Gly Gly Xaa Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
                85                  90                  95      


Gly Gly Gly Gly Gly Gly Gly Gly Xaa Gly Gly Gly Gly Gly Gly Gly 
            100                 105                 110         


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Xaa Gly Gly 
        115                 120                 125             


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
    130                 135                 140                 


Gly Gly Xaa Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
145                 150                 155                 160 


Gly Gly Gly Gly Gly Gly Gly Xaa Gly Gly Gly Gly Gly Gly Gly Gly 
                165                 170                 175     


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Xaa Gly Gly Gly 
            180                 185                 190         


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
        195                 200                 205             


Gly Xaa Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
    210                 215                 220                 


Gly Gly Gly Gly Gly Gly Xaa Gly Gly Gly Gly Gly Gly Gly Gly Gly 
225                 230                 235                 240 


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Xaa Gly Gly Gly Gly 
                245                 250                 255     


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
            260                 265                 270         


Xaa Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
        275                 280                 285             


Gly Gly Gly Gly Gly Xaa Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly 
    290                 295                 300                 


Gly Gly Gly Gly Gly Gly Gly Gly Gly Gly Xaa 
305                 310                 315 


<210> 29
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 29
Thr Leu Asp Asp Met Ser His Val Ile Leu Tyr Ala 
1               5                   10          


<210> 30
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 30
Val Ile Ser Asp Asn His Gln Ile Val Trp Asp Leu 
1               5                   10          


<210> 31
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 31
Leu Thr Thr Gln Asp His Pro Leu Thr Ile Leu Leu 
1               5                   10          


<210> 32
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 32
Gly Gly Trp Ile Cys His Trp Leu Glu Pro Gln Glu Ala Cys Thr Tyr 
1               5                   10                  15      


<210> 33
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 33
Gly Gly Cys Phe Glu Glu His Glu Gln Leu Val Phe Gln Thr His Cys 
1               5                   10                  15      


<210> 34
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 34
Gly Gly Cys Ile Leu Pro Gly Gln His Glu Ser Gln Ala Ile Ala Cys 
1               5                   10                  15      


<210> 35
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 35
Gly Gly Cys Leu Ser Gln Met Asp Phe His Asp Trp Leu Gln Tyr Cys 
1               5                   10                  15      


<210> 36
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 36
Gly Gly Thr Asp Cys Tyr Leu Trp Asp Tyr Lys Ala Ser Cys His Gln 
1               5                   10                  15      


<210> 37
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 37
Gly Gly Lys Cys Asp Ser Leu Ser Tyr Trp Gln Glu Ile Glu Cys Ser 
1               5                   10                  15      


<210> 38
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 38
Gly Gly Ala Asp Cys Leu Leu His Asp Trp Asp Ser Ala Cys Gln Ile 
1               5                   10                  15      


<210> 39
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 39
Met Gln Asn Val Asp Glu Ala Pro Pro Leu Leu Leu 
1               5                   10          


<210> 40
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 40
Thr Asn Asp Trp Gln Gly Leu Leu Leu Asn Val Phe 
1               5                   10          


<210> 41
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 41
Gly Gly Cys Gln Asp Ser Met Phe His His Pro Asn His Cys 
1               5                   10                  


<210> 42
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 42
Gly Gly Cys Gly Met His Gln His Pro Leu Phe Val Asp Cys 
1               5                   10                  


<210> 43
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 43
Gly Gly Cys Ser Leu Ser Gln His Pro Asn His Ser Asp Cys 
1               5                   10                  


<210> 44
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 44
Gly Gly Pro Cys Asn Gln Val Glu Cys His His Gln Phe Thr 
1               5                   10                  


<210> 45
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 45
Gly Gly Cys Pro Ser Leu His Pro Gln Trp Ile His Val Cys 
1               5                   10                  


<210> 46
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 46
Gly Gly Cys Phe Asp Ser Ala Asn Gln His Pro Asn Met Cys 
1               5                   10                  


<210> 47
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 47
Gly Gly Cys His Gln Asp Ile His His Pro Ile Tyr Trp Cys 
1               5                   10                  


<210> 48
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 48
Gly Gly Cys Gln Ile His Asp Pro His Thr Trp His Leu Cys 
1               5                   10                  


<210> 49
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 49
Gln Leu Phe Tyr Pro Ser Thr Tyr His Ile Ile Asp 
1               5                   10          


<210> 50
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 50
Gln Val Ser Pro Leu Tyr Phe Tyr Glu Glu Leu Ala 
1               5                   10          


<210> 51
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 51
His Gln Ala Leu Leu Asp Phe Tyr Gly Asp Tyr 
1               5                   10      


<210> 52
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 52
Gly Gly Met Cys His Glu Leu Phe Tyr Ser Asn Leu Asn Trp Cys Gln 
1               5                   10                  15      


<210> 53
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 53
Gly Gly His Cys Val Asp Met Val Asp Phe Tyr Gln Gln Thr Cys Gln 
1               5                   10                  15      


<210> 54
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 54
Val Asp Leu Leu Asp Gly Ser Leu Gln Asp Phe Tyr 
1               5                   10          


<210> 55
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 55
Gly Gly Leu Cys Ser Thr Phe Tyr Glu Pro Gln Val Asp Ile Cys Tyr 
1               5                   10                  15      


<210> 56
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 56
Ser Asp Phe Ser Gly Leu Leu Phe Tyr Asp Tyr Gln 
1               5                   10          


<210> 57
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 57
Gly Gly Cys Val His Phe Phe His His Gln Arg Pro Asp Cys 
1               5                   10                  


<210> 58
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 58
Gly Gly Cys His Asn Lys Ser Gly Leu Phe Tyr His Tyr Cys 
1               5                   10                  


<210> 59
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 59
Gly Gly Cys Phe Tyr Pro Gly His His His Gln Leu Leu Cys 
1               5                   10                  


<210> 60
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 60
Gly Ser Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Gly Ser 
1               5                   10                  15      


Gly Gly Gly Ser Gly Gly Ser Ser Gly Thr 
            20                  25      


<210> 61
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 61
Pro Cys Asn Gln Val Glu Cys His His Gln Phe Thr 
1               5                   10          


<210> 62
<211> 219
<212> PRT
<213> Mus sp.

<400> 62
Asp Ile Val Met Thr Gln Thr Thr Leu Ser Leu Pro Val Ser Leu Gly 
1               5                   10                  15      


Asp Gln Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Ile Val His Ser 
            20                  25                  30          


Asn Gly Asn Thr Tyr Leu Glu Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Lys Leu Leu Ile Tyr Lys Val Ser Asn Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Leu Gly Val Tyr Tyr Cys Phe Gln Gly 
                85                  90                  95      


Ser His Val Pro Tyr Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


Arg Ala Asp Ala Ala Pro Thr Val Ser Ile Phe Pro Pro Ser Ser Glu 
        115                 120                 125             


Gln Leu Thr Ser Gly Gly Ala Ser Val Val Cys Phe Leu Asn Asn Phe 
    130                 135                 140                 


Tyr Pro Lys Asp Ile Asn Val Lys Trp Lys Ile Asp Gly Ser Glu Arg 
145                 150                 155                 160 


Gln Asn Gly Val Leu Asn Ser Trp Thr Asp Gln Asp Ser Lys Asp Ser 
                165                 170                 175     


Thr Tyr Ser Met Ser Ser Thr Leu Thr Leu Thr Lys Asp Glu Tyr Glu 
            180                 185                 190         


Arg His Asn Ser Tyr Thr Cys Glu Ala Thr His Lys Thr Ser Thr Ser 
        195                 200                 205             


Pro Ile Val Lys Ser Phe Asn Arg Asn Glu Cys 
    210                 215                 


<210> 63
<211> 261
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 63
Gly Gly Ala Asp Cys Leu Leu His Asp Trp Asp Ser Ala Cys Gln Ile 
1               5                   10                  15      


Gly Ser Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Gly Ser 
            20                  25                  30          


Gly Gly Gly Ser Gly Gly Ser Ser Gly Thr Asp Ile Val Met Thr Gln 
        35                  40                  45              


Thr Thr Leu Ser Leu Pro Val Ser Leu Gly Asp Gln Ala Ser Ile Ser 
    50                  55                  60                  


Cys Arg Ser Ser Gln Ser Ile Val His Ser Asn Gly Asn Thr Tyr Leu 
65                  70                  75                  80  


Glu Trp Tyr Leu Gln Lys Pro Gly Gln Ser Pro Lys Leu Leu Ile Tyr 
                85                  90                  95      


Lys Val Ser Asn Arg Phe Ser Gly Val Pro Asp Arg Phe Ser Gly Ser 
            100                 105                 110         


Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile Ser Arg Val Glu Ala Glu 
        115                 120                 125             


Asp Leu Gly Val Tyr Tyr Cys Phe Gln Gly Ser His Val Pro Tyr Thr 
    130                 135                 140                 


Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Arg Ala Asp Ala Ala Pro 
145                 150                 155                 160 


Thr Val Ser Ile Phe Pro Pro Ser Ser Glu Gln Leu Thr Ser Gly Gly 
                165                 170                 175     


Ala Ser Val Val Cys Phe Leu Asn Asn Phe Tyr Pro Lys Asp Ile Asn 
            180                 185                 190         


Val Lys Trp Lys Ile Asp Gly Ser Glu Arg Gln Asn Gly Val Leu Asn 
        195                 200                 205             


Ser Trp Thr Asp Gln Asp Ser Lys Asp Ser Thr Tyr Ser Met Ser Ser 
    210                 215                 220                 


Thr Leu Thr Leu Thr Lys Asp Glu Tyr Glu Arg His Asn Ser Tyr Thr 
225                 230                 235                 240 


Cys Glu Ala Thr His Lys Thr Ser Thr Ser Pro Ile Val Lys Ser Phe 
                245                 250                 255     


Asn Arg Asn Glu Cys 
            260     


<210> 64
<211> 259
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 64
Gly Gly Cys Gln Asp Ser Met Phe His His Pro Asn His Cys Gly Ser 
1               5                   10                  15      


Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Gly Ser Gly Gly 
            20                  25                  30          


Gly Ser Gly Gly Ser Ser Gly Thr Asp Ile Val Met Thr Gln Thr Thr 
        35                  40                  45              


Leu Ser Leu Pro Val Ser Leu Gly Asp Gln Ala Ser Ile Ser Cys Arg 
    50                  55                  60                  


Ser Ser Gln Ser Ile Val His Ser Asn Gly Asn Thr Tyr Leu Glu Trp 
65                  70                  75                  80  


Tyr Leu Gln Lys Pro Gly Gln Ser Pro Lys Leu Leu Ile Tyr Lys Val 
                85                  90                  95      


Ser Asn Arg Phe Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Gly Ser 
            100                 105                 110         


Gly Thr Asp Phe Thr Leu Lys Ile Ser Arg Val Glu Ala Glu Asp Leu 
        115                 120                 125             


Gly Val Tyr Tyr Cys Phe Gln Gly Ser His Val Pro Tyr Thr Phe Gly 
    130                 135                 140                 


Gly Gly Thr Lys Leu Glu Ile Lys Arg Ala Asp Ala Ala Pro Thr Val 
145                 150                 155                 160 


Ser Ile Phe Pro Pro Ser Ser Glu Gln Leu Thr Ser Gly Gly Ala Ser 
                165                 170                 175     


Val Val Cys Phe Leu Asn Asn Phe Tyr Pro Lys Asp Ile Asn Val Lys 
            180                 185                 190         


Trp Lys Ile Asp Gly Ser Glu Arg Gln Asn Gly Val Leu Asn Ser Trp 
        195                 200                 205             


Thr Asp Gln Asp Ser Lys Asp Ser Thr Tyr Ser Met Ser Ser Thr Leu 
    210                 215                 220                 


Thr Leu Thr Lys Asp Glu Tyr Glu Arg His Asn Ser Tyr Thr Cys Glu 
225                 230                 235                 240 


Ala Thr His Lys Thr Ser Thr Ser Pro Ile Val Lys Ser Phe Asn Arg 
                245                 250                 255     


Asn Glu Cys 
            


<210> 65
<211> 259
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 65
Gly Gly Cys Ser Leu Ser Gln His Pro Asn His Ser Asp Cys Gly Ser 
1               5                   10                  15      


Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Gly Ser Gly Gly 
            20                  25                  30          


Gly Ser Gly Gly Ser Ser Gly Thr Asp Ile Val Met Thr Gln Thr Thr 
        35                  40                  45              


Leu Ser Leu Pro Val Ser Leu Gly Asp Gln Ala Ser Ile Ser Cys Arg 
    50                  55                  60                  


Ser Ser Gln Ser Ile Val His Ser Asn Gly Asn Thr Tyr Leu Glu Trp 
65                  70                  75                  80  


Tyr Leu Gln Lys Pro Gly Gln Ser Pro Lys Leu Leu Ile Tyr Lys Val 
                85                  90                  95      


Ser Asn Arg Phe Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Gly Ser 
            100                 105                 110         


Gly Thr Asp Phe Thr Leu Lys Ile Ser Arg Val Glu Ala Glu Asp Leu 
        115                 120                 125             


Gly Val Tyr Tyr Cys Phe Gln Gly Ser His Val Pro Tyr Thr Phe Gly 
    130                 135                 140                 


Gly Gly Thr Lys Leu Glu Ile Lys Arg Ala Asp Ala Ala Pro Thr Val 
145                 150                 155                 160 


Ser Ile Phe Pro Pro Ser Ser Glu Gln Leu Thr Ser Gly Gly Ala Ser 
                165                 170                 175     


Val Val Cys Phe Leu Asn Asn Phe Tyr Pro Lys Asp Ile Asn Val Lys 
            180                 185                 190         


Trp Lys Ile Asp Gly Ser Glu Arg Gln Asn Gly Val Leu Asn Ser Trp 
        195                 200                 205             


Thr Asp Gln Asp Ser Lys Asp Ser Thr Tyr Ser Met Ser Ser Thr Leu 
    210                 215                 220                 


Thr Leu Thr Lys Asp Glu Tyr Glu Arg His Asn Ser Tyr Thr Cys Glu 
225                 230                 235                 240 


Ala Thr His Lys Thr Ser Thr Ser Pro Ile Val Lys Ser Phe Asn Arg 
                245                 250                 255     


Asn Glu Cys 
            


<210> 66
<211> 259
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 66
Gly Gly Pro Cys Asn Gln Val Glu Cys His His Gln Phe Thr Gly Ser 
1               5                   10                  15      


Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Gly Ser Gly Gly 
            20                  25                  30          


Gly Ser Gly Gly Ser Ser Gly Thr Asp Ile Val Met Thr Gln Thr Thr 
        35                  40                  45              


Leu Ser Leu Pro Val Ser Leu Gly Asp Gln Ala Ser Ile Ser Cys Arg 
    50                  55                  60                  


Ser Ser Gln Ser Ile Val His Ser Asn Gly Asn Thr Tyr Leu Glu Trp 
65                  70                  75                  80  


Tyr Leu Gln Lys Pro Gly Gln Ser Pro Lys Leu Leu Ile Tyr Lys Val 
                85                  90                  95      


Ser Asn Arg Phe Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Gly Ser 
            100                 105                 110         


Gly Thr Asp Phe Thr Leu Lys Ile Ser Arg Val Glu Ala Glu Asp Leu 
        115                 120                 125             


Gly Val Tyr Tyr Cys Phe Gln Gly Ser His Val Pro Tyr Thr Phe Gly 
    130                 135                 140                 


Gly Gly Thr Lys Leu Glu Ile Lys Arg Ala Asp Ala Ala Pro Thr Val 
145                 150                 155                 160 


Ser Ile Phe Pro Pro Ser Ser Glu Gln Leu Thr Ser Gly Gly Ala Ser 
                165                 170                 175     


Val Val Cys Phe Leu Asn Asn Phe Tyr Pro Lys Asp Ile Asn Val Lys 
            180                 185                 190         


Trp Lys Ile Asp Gly Ser Glu Arg Gln Asn Gly Val Leu Asn Ser Trp 
        195                 200                 205             


Thr Asp Gln Asp Ser Lys Asp Ser Thr Tyr Ser Met Ser Ser Thr Leu 
    210                 215                 220                 


Thr Leu Thr Lys Asp Glu Tyr Glu Arg His Asn Ser Tyr Thr Cys Glu 
225                 230                 235                 240 


Ala Thr His Lys Thr Ser Thr Ser Pro Ile Val Lys Ser Phe Asn Arg 
                245                 250                 255     


Asn Glu Cys 
            


<210> 67
<211> 453
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 67
Glu Ala Lys Leu Gln Glu Ser Gly Pro Val Leu Val Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Met Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asp Tyr 
            20                  25                  30          


Tyr Met Asn Trp Val Lys Gln Ser His Gly Lys Ser Leu Glu Trp Ile 
        35                  40                  45              


Gly Val Ile Asn Pro Tyr Asn Gly Asp Thr Ser Tyr Asn Gln Lys Phe 
    50                  55                  60                  


Lys Gly Lys Ala Thr Leu Thr Val Asp Lys Ser Ser Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Asn Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Tyr Tyr Gly Ser Trp Phe Ala Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Ile Thr Val Ser Thr Ala Lys Thr Thr Pro Pro Ser Val Tyr Pro Leu 
        115                 120                 125             


Ala Pro Gly Cys Gly Asp Thr Thr Gly Ser Ser Val Thr Leu Gly Cys 
    130                 135                 140                 


Leu Val Lys Gly Tyr Phe Pro Glu Ser Val Thr Val Thr Trp Asn Ser 
145                 150                 155                 160 


Gly Ser Leu Ser Ser Ser Val His Thr Phe Pro Ala Leu Leu Gln Ser 
                165                 170                 175     


Gly Leu Tyr Thr Met Ser Ser Ser Val Thr Val Pro Ser Ser Thr Trp 
            180                 185                 190         


Pro Ser Gln Thr Val Thr Cys Ser Val Ala His Pro Ala Ser Ser Thr 
        195                 200                 205             


Thr Val Asp Lys Lys Leu Glu Pro Ser Gly Pro Ile Ser Thr Ile Asn 
    210                 215                 220                 


Pro Cys Pro Pro Cys Lys Glu Cys His Lys Cys Pro Ala Pro Asn Leu 
225                 230                 235                 240 


Glu Gly Gly Pro Ser Val Phe Ile Phe Pro Pro Asn Ile Lys Asp Val 
                245                 250                 255     


Leu Met Ile Ser Leu Thr Pro Lys Val Thr Cys Val Val Val Asp Val 
            260                 265                 270         


Ser Glu Asp Asp Pro Asp Val Arg Ile Ser Trp Phe Val Asn Asn Val 
        275                 280                 285             


Glu Val His Thr Ala Gln Thr Gln Thr His Arg Glu Asp Tyr Asn Ser 
    290                 295                 300                 


Thr Ile Arg Val Val Ser Ala Leu Pro Ile Gln His Gln Asp Trp Met 
305                 310                 315                 320 


Ser Gly Lys Glu Phe Lys Cys Lys Val Asn Asn Lys Asp Leu Pro Ser 
                325                 330                 335     


Pro Ile Glu Arg Thr Ile Ser Lys Ile Lys Gly Leu Val Arg Ala Pro 
            340                 345                 350         


Gln Val Tyr Ile Leu Pro Pro Pro Ala Glu Gln Leu Ser Arg Lys Asp 
        355                 360                 365             


Val Ser Leu Thr Cys Leu Val Val Gly Phe Asn Pro Gly Asp Ile Ser 
    370                 375                 380                 


Val Glu Trp Thr Ser Asn Gly His Thr Glu Glu Asn Tyr Lys Asp Thr 
385                 390                 395                 400 


Ala Pro Val Leu Asp Ser Asp Gly Ser Tyr Phe Ile Tyr Ser Lys Leu 
                405                 410                 415     


Asp Ile Lys Thr Ser Lys Trp Glu Lys Thr Asp Ser Phe Ser Cys Asn 
            420                 425                 430         


Val Arg His Glu Gly Leu Lys Asn Tyr Tyr Leu Lys Lys Thr Ile Ser 
        435                 440                 445             


Arg Ser Pro Gly Lys 
    450             


<210> 68
<211> 214
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 68
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asp Val Ser Thr Ala 
            20                  25                  30          


Val Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ser Ala Ser Phe Leu Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Leu Tyr His Pro Ala 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val Ala Ala 
            100                 105                 110         


Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly 
        115                 120                 125             


Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala 
    130                 135                 140                 


Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln 
145                 150                 155                 160 


Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser 
                165                 170                 175     


Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr 
            180                 185                 190         


Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser 
        195                 200                 205             


Phe Asn Arg Gly Glu Cys 
    210                 


<210> 69
<211> 256
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 69
Gly Gly His Cys Val Asp Met Val Asp Phe Tyr Gln Gln Thr Cys Gln 
1               5                   10                  15      


Gly Ser Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Gly Ser 
            20                  25                  30          


Gly Gly Gly Ser Gly Gly Ser Ser Gly Thr Asp Ile Gln Met Thr Gln 
        35                  40                  45              


Ser Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr 
    50                  55                  60                  


Cys Arg Ala Ser Gln Asp Val Ser Thr Ala Val Ala Trp Tyr Gln Gln 
65                  70                  75                  80  


Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Ser Ala Ser Phe Leu 
                85                  90                  95      


Tyr Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp 
            100                 105                 110         


Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr 
        115                 120                 125             


Tyr Cys Gln Gln Tyr Leu Tyr His Pro Ala Thr Phe Gly Gln Gly Thr 
    130                 135                 140                 


Lys Val Glu Ile Lys Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe 
145                 150                 155                 160 


Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys 
                165                 170                 175     


Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val 
            180                 185                 190         


Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln 
        195                 200                 205             


Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser 
    210                 215                 220                 


Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala Cys Glu Val Thr His 
225                 230                 235                 240 


Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys 
                245                 250                 255     


<210> 70
<211> 448
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 70
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asp Ser 
            20                  25                  30          


Trp Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Trp Ile Ser Pro Tyr Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Ala Asp Thr Ser Lys Asn Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Arg His Trp Pro Gly Gly Phe Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro 
        115                 120                 125             


Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly 
    130                 135                 140                 


Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp Asn 
145                 150                 155                 160 


Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu Gln 
                165                 170                 175     


Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser Ser 
            180                 185                 190         


Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro Ser 
        195                 200                 205             


Asn Thr Lys Val Asp Lys Lys Val Glu Pro Lys Ser Cys Asp Lys Thr 
    210                 215                 220                 


His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser 
225                 230                 235                 240 


Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg 
                245                 250                 255     


Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro 
            260                 265                 270         


Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala 
        275                 280                 285             


Lys Thr Lys Pro Arg Glu Glu Gln Tyr Ala Ser Thr Tyr Arg Val Val 
    290                 295                 300                 


Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr 
305                 310                 315                 320 


Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr 
                325                 330                 335     


Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu 
            340                 345                 350         


Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys 
        355                 360                 365             


Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser 
    370                 375                 380                 


Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp 
385                 390                 395                 400 


Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser 
                405                 410                 415     


Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala 
            420                 425                 430         


Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys 
        435                 440                 445             



